DOXYCYCLINE HYCLATE | N050533 | PFIZER LABORATORIES DIV PFIZER INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Suitability Petition from HYMAN, PHELPS & MCNAMARA, P.C. FDA-2021-P-0928 Hyman, Phelps & McNamara P.C. filed this suitability petition under Section 505(j)(2)(C) of the Federal Food, Drug and Cosmetic Act requesting that the FDA declare Doxycycline Hyclate Tablets, 20 mg, suitable for submission as an Abbreviated New Drug Application, with the Reference Listed Drug being | Suitability | 2021-08-23 | Open | HYMAN |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.